Medical Letter on the CDC & FDA
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Angiology
Inflammatory cytokines referee angiogenic control during inflammation
September 5th, 2004
Inflammatory cytokines referee angiogenic control during inflammation. "Vigorous inflammatory responses are associated with tissue damage, particularly when toxic levels of inflammatory cytokines are produced. Despite proangiogenic factors being present early at sites of inflammation, vascular repair occurs toward the end of the inflammatory response, suggesting modulation of the proangiogenic response. Endogenous inhibitors of angiogenesis induced during acute inflammation are poorly characterized," scientists writing in the Journal of Leukocyte Biology report. "Here, we looked for endothelial cell-derived modulators of angiogenesis that may...
Source: Medical Letter on the CDC & FDA (2004-09-05)
|
